Preventive Medicine and Public Health Department, Virgen de la Victoria University Hospital, Málaga, Spain.
EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.
PLoS One. 2024 Sep 26;19(9):e0297702. doi: 10.1371/journal.pone.0297702. eCollection 2024.
Multimorbidity is one of the biggest challenges faced by modern medicine, especially when managing older patients who are also often taking multiple medications. Multimorbidity is influenced by social determinants of health, giving rise to health inequalities in the population. Here, we sought to determine the influence of social determinants of health on quality of life in patients with multimorbidity and polypharmacy.
This cross-sectional observational study included 573 patients aged 65-74 with multimorbidity (≥3 diseases) and polypharmacy (≥5 drugs). Corresponding data was taken drawn from the Spanish MULTIPAP study, and included social and demographic variables, and data on health-related quality of life and overall self-perceived health status, assessed using the 5-level version of the EuroQol 5-dimensional questionnaire (EQ-5D-5L). Descriptive, bivariate and multivariate analyses with logistic regression models were performed.
Mean patient age was 69.7 years, 55.8% of patients were female, 59.7% belonged to low social classes (V, VI), a monthly income of €1051-€1850 predominated, and the median number of diseases in the same patient was 6. Factors associated with higher quality of life were (odds ratio, OR) male gender (OR = 1.599, p = 0.013), a higher educational level (OR = 1.991, p = 0.036), an absence of urban vulnerability (OR = 1.605, p = 0.017), and the presence of medium social support (OR = 1.689, p = 0.017). Having a higher number of diseases was associated with poorer quality of life (OR = 0.912, p = 0.017).
Our findings describe associations between social determinants of health and quality of life in patients aged 65-74 years with multimorbidity and polypharmacy. More illnesses, female gender, a lower education level, urban vulnerability, and less social support are associated with poorer quality of life, underscoring the need for a biopsychosocial approach in patient care.
多种疾病共存是现代医学面临的最大挑战之一,尤其是在管理同时经常服用多种药物的老年患者时。多种疾病共存受健康社会决定因素的影响,导致人群健康不平等。在这里,我们试图确定健康社会决定因素对患有多种疾病和多种药物的患者生活质量的影响。
这项横断面观察性研究包括 573 名年龄在 65-74 岁之间的患有多种疾病(≥3 种疾病)和多种药物(≥5 种药物)的患者。相应的数据取自西班牙 MULTIPAP 研究,包括社会和人口统计学变量,以及使用欧洲五维健康问卷 5 级版本(EQ-5D-5L)评估的健康相关生活质量和总体自我感知健康状况的数据。进行了描述性、双变量和多变量分析以及逻辑回归模型。
患者平均年龄为 69.7 岁,55.8%的患者为女性,59.7%属于低社会阶层(V、VI),月收入为 1051-1850 欧元,同一患者的中位数疾病数为 6。与更高生活质量相关的因素是(优势比,OR)男性(OR=1.599,p=0.013)、更高的教育水平(OR=1.991,p=0.036)、无城市脆弱性(OR=1.605,p=0.017)和中等社会支持(OR=1.689,p=0.017)。患有更多疾病与生活质量较差相关(OR=0.912,p=0.017)。
我们的研究结果描述了 65-74 岁患有多种疾病和多种药物的患者的健康社会决定因素与生活质量之间的关联。更多的疾病、女性、较低的教育水平、城市脆弱性和较少的社会支持与较差的生活质量相关,这凸显了在患者护理中采用生物心理社会方法的必要性。